Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 8/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30080260 | 0.82 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL4937834 | 0.81 | ACHE (0.36) | ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL2773916 | 0.80 | KCNH2 (0.36) | ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL23699790 | 0.78 | ACHE (0.41) | ACHE | |
| SCHEMBL30716694 | 0.77 | PIK3CD (0.33) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL15398475 | 0.76 | KCNH2 (0.43) | — | |
| Bromide SCHEMBL198106 | 0.75 | PIK3CD (0.32) | — | |
| Hydrochloric Acid SCHEMBL1408651 | 0.75 | PIK3CD (0.32) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL3782746 | 0.74 | KCNH2 (0.45) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL3779474 | 0.74 | KCNH2 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10622679-B2 | Method for manufacturing fluoride ion conducting electrolyte solution and method for manufacturing fluoride ion battery | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2020-04-14 | — | — | US | disclosed |
| US-20160285129-A1 | METHOD FOR MANUFACTURING FLUORIDE ION CONDUCTING ELECTROLYTE SOLUTION AND METHOD FOR MANUFACTURING FLUORIDE ION BATTERY | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2016-09-29 | — | — | US | disclosed |
| US-20120327511-A1 | OPTICAL FILM, METHOD OF PRODUCING OPTICAL FILM, POLARIZING PLATE, DISPLAY PANEL, AND DISPLAY | DAI NIPPON PRINTING CO., LTD. (JP) | 2012-12-27 | — | — | US | disclosed |
| US-20080221353-A1 | Novel phosphonium salt ionic liquid and reaction solvent including the same | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2008-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221353-A1 | Novel phosphonium salt ionic liquid and reaction solvent including the same | PIK3R5, PIP4K2B, PIP5K1B | ACHE 3493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.